Organon Balance Sheet Health
Financial Health criteria checks 1/6
Organon has a total shareholder equity of $48.0M and total debt of $8.7B, which brings its debt-to-equity ratio to 18154.2%. Its total assets and total liabilities are $11.9B and $11.8B respectively. Organon's EBIT is $1.3B making its interest coverage ratio 2.6. It has cash and short-term investments of $575.0M.
Key information
18,154.2%
Debt to equity ratio
US$8.71b
Debt
| Interest coverage ratio | 2.6x |
| Cash | US$575.00m |
| Equity | US$48.00m |
| Total liabilities | US$11.84b |
| Total assets | US$11.89b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7XP's short term assets ($4.2B) exceed its short term liabilities ($2.5B).
Long Term Liabilities: 7XP's short term assets ($4.2B) do not cover its long term liabilities ($9.3B).
Debt to Equity History and Analysis
Debt Level: 7XP's net debt to equity ratio (16956.3%) is considered high.
Reducing Debt: 7XP's debt to equity ratio has increased from 2.4% to 18154.2% over the past 5 years.
Debt Coverage: 7XP's debt is not well covered by operating cash flow (8.7%).
Interest Coverage: 7XP's interest payments on its debt are not well covered by EBIT (2.6x coverage).